NCT05501210 Vibration on Patellofemoral Joint Pain After ACLR
| NCT ID | NCT05501210 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Anterior Cruciate Ligament Injuries |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2022-03-01 |
| Primary Completion | 2029-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2022-03-01 with a primary completion date of 2029-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Anterior cruciate ligament (ACL) injury is a prevailing problem among sports participants, especially in non-contact sports. Studies have reported that 70-84% of ACL injuries are non-contact in nature, and movements like changing in direction while running, cutting and pivoting on a planted foot have resulted in a majority of ACL injuries. Even after ACL reconstruction (ACLR) surgeries, study has reported a 30-50% prevalence of developing patellofemoral joint (PFJ) pain in 1-2 years post-operation. Whole body vibration (WBV) therapy has been gaining attention as an effective method of training in recent years. It has been proved to have a positive effect on improving muscle strength, muscle activities, muscle power and loading during drop jump. Though duration of WBV may differ according to the effect of interest, several studies have had positive results with a 8 week WBV therapy in increasing muscle strength, proprioception, and post-ACLR knee functions. Further investigation on the underlying mechanism and possible application are to be continued to explore more possibilities with the WBV therapy.
Eligibility Criteria
Inclusion Criteria: 1. Age between 18 to 60 2. Unilateral ACLR 3. Persisting PFJ pain 4. Isolated symptomatic site or pathology Exclusion Criteria: 1. Age \> 60 2. Bilateral ACLR 3. Revision ACLR 4. Any rheumatological diseases 5. Previous contralateral knee injury 6. Any knee osteoarthritis
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05501210 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Anterior Cruciate Ligament Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05501210 currently recruiting?
Yes, NCT05501210 is actively recruiting participants. Contact the research team at michael.ong@cuhk.edu.hk for enrollment information.
Where is the NCT05501210 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT05501210 clinical trial?
NCT05501210 is sponsored by Chinese University of Hong Kong. The trial plans to enroll 50 participants.